Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stribild vs Ritonavir-Boosted Atazanavir + Truvada in HIV-1 Infected Women (WAVES)
NCT01705574Phase 3Completed
- Sponsor
- Gilead Sciences
- Start
- Oct 2012
- Primary completion
- Feb 2015
- Countries
- 12
01
Overview
A Phase 3 trial of emtricitabine + elvitegravir + cobicistat + tenofovir disoproxil in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Gilead Sciences. Started Oct 2012; status: completed.
02
Drugs
emtricitabine + elvitegravir + cobicistat + tenofovir disoproxil
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT01705574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01705574.